Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

Peer worker or client?: conflicting identities among peer workers engaged in harm reduction service delivery

This study sought to identify challenges surrounding peer programming in Ottawa and to provide realistic recommendations for reducing these barriers.

Original research | 2017

About PWUD, Workplace, Peer/PWLLE program involvement

Pharmacists Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies: Notification to all pharmacists in the Vancouver Coastal Health (VCH) region

Pharmacists Guidelines for risk mitigation in BC from Vancouver Coastal Health

Guidelines | 2020

Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About pharmacists, Stimulants, Substitution/OAT, Injecting drugs

Predicting the impact of placing an overdose prevention site in Philadelphia: a mathematical modeling approach

As urban centers in the USA are tackling legal hurdles and community skepticism around the introduction and location of these sites, it becomes increasingly important to assess the magnitude of the ef

Original research | 2021

Overdose, Mortality, Evidence base, Equity, Outcomes, Illegal drugs, SCS/OPS

Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies: Notification to All Prescribers in the Vancouver Coastal Health (VCH) Region

Prescriber Guidelines for risk mitigation in BC from Vancouver Coastal Health

Guidelines | 2020

Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About prescribers, Stimulants, Substitution/OAT, Injecting drugs

Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response

To understand the most effective ways to deliver HR in pandemic situations so that guidance can be provided for current and future disruptions to service provisions

Lit review | 2020

Policy/Regulatory, Equity, Substitution/OAT

Regulatory oversight of behavioral digital therapeutics for addiction treatment: A commentary on Khadjesari et al.

Commentary | 2021

Policy/Regulatory, Digital health

Safer opioid distribution in response to the COVID-19 pandemic

Commentary | 2020

Safer supply, Advocacy

The drug war must end: The right to life, liberty and security of the person during the COVID-19 pandemic for people who use drugs

Decriminalization

Commentary | 2021

Policy/Regulatory, Decriminalization/legalization, About PWUD

The Politics of "People With Lived Experience": Experiential Authority and the Risks of Strategic Essentialism

I engage longstanding feminist, postcolonial, and post-structural philosophical debates that have queried the possibilities, limits, and conditions of drawing on experience as expertise, and apply the

Commentary | 2016

Advocacy, Peer/PWLLE program involvement

The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users

Critically question the impacts of drug checking as a harm reduction response

Original research | 2021

Harm reduction, Policy/Regulatory, Safer supply, Advocacy, About PWUD, Illegal drugs, Drug checking

There is no causality in the "gateway hypothesis": Another test gone amiss

This letter responds to the article by Reed et al. [1].

Letter | 2021

Evidence base

A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting

Very little is known about the value of UDS, the optimum screening frequency in general, or its specific use for buprenorphine treatment in primary care.

Original research | 2021

Clinical guidance, About prescribers, Outcomes, Substitution/OAT, Diversion

Acceptability, Feasibility, and Pilot Results of the Tele-Harm Reduction Intervention for Rapid Initiation of Antiretrovirals among People Who Inject Drugs

Tele-Harm Reduction (THR) is a telehealth-enhanced, harm reduction intervention, delivered within a trusted SSP venue.

Original research | 2021

About PWUD, Illegal drugs, Digital health

Assessing open science and citizen science in addictions and substance use research: A scoping review

This paper explores both current barriers and potential facilitators for the implementation of Open Science and Citizen Science in substance use and addictions research.

Scoping review | 2022

Equity, About PWUD, Peer/PWLLE program involvement

Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine

This review synthesizes the literature on the perspectives and experiences of people who use drugs to better understand motivations and behaviors related to the extramedical use and diversion of bupre

Lit review | 2021

About prescribers, About PWUD, Substitution/OAT, Stigma, Diversion

Comparisons of Injection and Non-Injection Opioid Use among Black People in Methadone Treatment: A Pilot Study in Detroit

Rates of injection drug use (IDU) of opioids have been consistently lower among Black people relative to Non-Hispanic White people despite rising IDU estimates.

Original research | 2021

Equity, About PWUD, Legal system/law enforcement, Illegal drugs, Substitution/OAT, Mental health

Cool Aid Community Health Centre Report on Risk Mitigation Guidance Prescriptions: Providing “Safer Supply” in CAMICO Sheltering Sites, Outreach and Primary Care Practice

The primary aims of this report were to: 1. Describe the RMG program at the CACHC; 2. Describe the characteristics of clients participating in RMG through the CACHC; 3.

Report | 2020

Overdose, Evidence base, Harm reduction, Policy/Regulatory, Wrap-around services, Safer supply, Advocacy, About prescribers, Outcomes, Housing, Youth, Chronic pain